Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 8 de 8
Filtrer
1.
J Pediatr ; 229: 259-266, 2021 02.
Article de Anglais | MEDLINE | ID: mdl-32890584

RÉSUMÉ

OBJECTIVE: To use medical claims data to determine patterns of healthcare utilization in children with intellectual and developmental disabilities, including frequency of service utilization, conditions that require hospital care, and costs. STUDY DESIGN: Medicaid administrative claims from 4 states (Iowa, Massachusetts, New York, and South Carolina) from years 2008-2013 were analyzed, including 108 789 children (75 417 male; 33 372 female) under age 18 years with intellectual and developmental disabilities. Diagnoses included cerebral palsy, autism, fetal alcohol syndrome, Down syndrome/trisomy/autosomal deletions, other genetic conditions, and intellectual disability. Utilization of emergency department (ED) and inpatient hospital services were analyzed for 2012. RESULTS: Children with intellectual and developmental disabilities used both inpatient and ED care at 1.8 times that of the general population. Epilepsy/convulsions was the most frequent reason for hospitalization at 20 times the relative risk of the general population. Other frequent diagnoses requiring hospitalization were mood disorders, pneumonia, paralysis, and asthma. Annual per capita expenses for hospitalization and ED care were 100% higher for children with intellectual and developmental disabilities, compared with the general population ($153 348 562 and $76 654 361, respectively). CONCLUSIONS: Children with intellectual and developmental disabilities utilize significantly more ED and inpatient care than other children, which results in higher annual costs. Recognizing chronic conditions that increase risk for hospital care can provide guidance for developing outpatient care strategies that anticipate common clinical problems in intellectual and developmental disabilities and ensure responsive management before hospital care is needed.


Sujet(s)
Incapacités de développement/économie , Service hospitalier d'urgences/économie , Service hospitalier d'urgences/statistiques et données numériques , Utilisation des installations et des services/économie , Utilisation des installations et des services/statistiques et données numériques , Coûts des soins de santé , Hospitalisation/économie , Hospitalisation/statistiques et données numériques , Déficience intellectuelle/économie , Adolescent , Enfant , Enfant d'âge préscolaire , Incapacités de développement/thérapie , Femelle , Humains , Nourrisson , Déficience intellectuelle/thérapie , Iowa , Mâle , Massachusetts , État de New York , Caroline du Sud
2.
J Autism Dev Disord ; 48(5): 1780-1791, 2018 05.
Article de Anglais | MEDLINE | ID: mdl-29247310

RÉSUMÉ

Simple and low-cost observational-tools to detect symptoms of Autism Spectrum Disorder (ASD) are still necessary. The OERA is a new assessment tool to screen children eliciting observable behaviors with no substantial knowledge on ASD required. The sample was 99 children aged 3-10: 76 with ASD and 23 without ASD (11/23 had intellectual disability). The 13 remained items exhibited high interrater agreement and high reliability loaded onto a single latent trait. Such model showed excellent fit indices evaluated via confirmatory factor analysis and no item showed differential function in terms of age/sex/IQ. A cutoff of five points or higher resulted in the highest sensitivity (92.75) and specificity (90.91) percentages. OERA is a brief, stable, low-cost standardized observational-screening to identify ASD children.


Sujet(s)
Trouble du spectre autistique/diagnostic , Trouble du spectre autistique/économie , Techniques d'observation du comportement/économie , Techniques d'observation du comportement/normes , Dépistage de masse/économie , Dépistage de masse/normes , Trouble du spectre autistique/psychologie , Enfant , Enfant d'âge préscolaire , Analyse coût-bénéfice , Analyse statistique factorielle , Femelle , Humains , Déficience intellectuelle/diagnostic , Déficience intellectuelle/économie , Déficience intellectuelle/psychologie , Mâle , Reproductibilité des résultats
3.
Salud pública Méx ; 58(6): 694-707, nov.-dic. 2016. graf
Article de Anglais | LILACS | ID: biblio-846016

RÉSUMÉ

Abstract: Objective: This study aims to generate evidence on intellectual development disorders (IDD) in Mexico. Materials and methods: IDD disease burden will be estimated with a probabilistic model, using population-based surveys. Direct and indirect costs of catastrophic expenses of families with a member with an IDD will be evaluated. Genomic characterization of IDD will include: sequencing participant exomes and performing bioinformatics analyses to identify de novo or inherited variants through trio analysis; identifying genetic variants associated with IDD, and validating randomly selected variants by polymerase chain reaction (PCR) and sequencing or real-time quantitative PCR (qPCR). Delphi surveys will be done on best practices for IDD diagnosis and management. An external evaluation will employ qualitative case studies of two social and labor inclusion programs for people with IDD. Conclusions: The results will constitute scientific evidence for the design, promotion and evaluation of public policies, which are currently absent on IDD.


Resumen: Objetivo: Esta investigación busca generar evidencia sobre trastornos del desarrollo intelectual (TDI) en México. Material y métodos: La carga de la enfermedad por TDI se estimará con un modelo probabilístico usando encuestas poblacionales. Se estimarán costos directos e indirectos de gastos catastróficos de familias con un integrante conTDI. La caracterización genómica deTDI incluirá secuenciar exomas, realizar análisis bioinformático para identificar variantes de novo o heredadas a través de análisis de tríos, identificar variantes genéticas asociadas con TDI, y validar variantes aleatoriamente seleccionadas con reacción en cadena de polimerasa y secuenciación o qPCR. Se harán encuestas Delphi sobre mejores prácticas de diagnóstico y manejo de TDI. Una evaluación externa empleará estudios cualitativos de caso de dos programas de inclusión social y laboral para personas con TDI. Conclusiones: Los resultados serán evidencia científica que podrá ser la base para el diseño, promoción y evaluación de políticas públicas, actualmente ausentes para TDI.


Sujet(s)
Humains , Déficience intellectuelle/diagnostic , Déficience intellectuelle/économie , Déficience intellectuelle/génétique , Déficience intellectuelle/thérapie , Variation génétique , Maladie catastrophique/économie , Enquêtes et questionnaires , Coûts indirects de la maladie , Troubles déficitaires de l'attention et du comportement perturbateur/diagnostic , Troubles déficitaires de l'attention et du comportement perturbateur/économie , Troubles déficitaires de l'attention et du comportement perturbateur/génétique , Troubles déficitaires de l'attention et du comportement perturbateur/thérapie , Coûts et analyse des coûts , Génomique , Obésité pédiatrique/diagnostic , Trouble du spectre autistique/diagnostic , Trouble du spectre autistique/thérapie , Mexique
4.
Salud Publica Mex ; 58(6): 694-707, 2016.
Article de Anglais | MEDLINE | ID: mdl-28225946

RÉSUMÉ

OBJECTIVE:: This study aims to generate evidence on intellectual development disorders (IDD) in Mexico. MATERIALS AND METHODS:: IDD disease burden will be estimated with a probabilistic model, using population-based surveys. Direct and indirect costs of catastrophic expenses of families with a member with an IDD will be evaluated. Genomic characterization of IDD will include: sequencing participant exomes and performing bioinformatics analyses to identify de novo or inherited variants through trio analysis; identifying genetic variants associated with IDD, and validating randomly selected variants by polymerase chain reaction (PCR) and sequencing or real-time quantitative PCR (qPCR). Delphi surveys will be done on best practices for IDD diagnosis and management. An external evaluation will employ qualitative case studies of two social and labor inclusion programs for people with IDD. CONCLUSIONS:: The results will constitute scientific evidence for the design, promotion and evaluation of public policies, which are currently absent on IDD.


Sujet(s)
Déficience intellectuelle , Troubles déficitaires de l'attention et du comportement perturbateur/diagnostic , Troubles déficitaires de l'attention et du comportement perturbateur/économie , Troubles déficitaires de l'attention et du comportement perturbateur/génétique , Troubles déficitaires de l'attention et du comportement perturbateur/thérapie , Trouble du spectre autistique/diagnostic , Trouble du spectre autistique/économie , Trouble du spectre autistique/génétique , Trouble du spectre autistique/thérapie , Maladie catastrophique/économie , Coûts indirects de la maladie , Coûts et analyse des coûts , Variation génétique , Génomique , Humains , Déficience intellectuelle/diagnostic , Déficience intellectuelle/économie , Déficience intellectuelle/génétique , Déficience intellectuelle/thérapie , Mexique , Obésité pédiatrique/diagnostic , Obésité pédiatrique/économie , Obésité pédiatrique/génétique , Obésité pédiatrique/thérapie , Enquêtes et questionnaires
5.
J Negat Results Biomed ; 11: 16, 2012 Dec 21.
Article de Anglais | MEDLINE | ID: mdl-23259705

RÉSUMÉ

BACKGROUND: Mental retardation (MR) is a heterogeneous condition that affects 2-3% of the general population and is a public health problem in developing countries. Chromosomal abnormalities are an important cause of MR and subtelomeric rearrangements (STR) have been reported in 4-35% of individuals with idiopathic MR or an unexplained developmental delay, depending on the screening tests and patient selection criteria used. Clinical checklists such as that suggested by de Vries et al. have been used to improve the predictive value of subtelomeric screening. FINDINGS: Fifteen patients (1-20 years old; five females and ten males) with moderate to severe MR from a genetics outpatient clinic of the Gaffrée and Guinle Teaching Hospital (HUGG) of the Federal University of Rio de Janeiro State (UNIRIO) were screened with Multiprobe T FISH after normal high resolution karyotyping. No subtelomeric rearrangements were detected even though the clinical score of the patients ranged from four to seven. CONCLUSION: In developing countries, FISH-based techniques such as Multiprobe T FISH are still expensive. Although Multiprobe T FISH is a good tool for detecting STR, in this study it did not detect STR in patients with unexplained MR/developmental delay even though these patients had a marked chromosomal imbalance. Our findings also show that clinical scores are not reliable predictors of STR.


Sujet(s)
Hybridation fluorescente in situ/méthodes , Déficience intellectuelle/diagnostic , Déficience intellectuelle/génétique , Télomère/génétique , Adolescent , Enfant , Enfant d'âge préscolaire , Études de cohortes , Pays en voie de développement/économie , Femelle , Humains , Hybridation fluorescente in situ/économie , Nourrisson , Déficience intellectuelle/économie , Mâle , Télomère/anatomopathologie , Jeune adulte
7.
J Pediatr ; 155(1): 21-5, 25.e1-5, 2009 Jul.
Article de Anglais | MEDLINE | ID: mdl-19394030

RÉSUMÉ

OBJECTIVE: To gather and calculate utilities for a wide range of health states in the pediatric population. STUDY DESIGN: The study subjects, parents or guardians at least 18 years of age with at least 1 child under age 18 years, were recruited through our Pediatric Research Network (PResNet). Recruitment locations included pediatric clinics, the Indiana State Fair, and public and private conventions. Each subject's utilities were assessed on 3 random health states out of 29 chosen for the study. Both the time trade-off and standard gamble methods were used to measure utilities. RESULTS: Utilities were assessed in a total of 4016 participants (a recruitment rate of 88%). Utility values ranged from a high for acute otitis media (0.96 by standard gamble; 0.97 by time trade-off) to a low for severe mental retardation (0.59 by standard gamble; 0.51 by time trade-off). CONCLUSIONS: Our extensive data set of utility assessments for a wide range of disease states can aid future economic evaluations of pediatric health care.


Sujet(s)
Techniques d'aide à la décision , État de santé , 29918 , Parents , Années de vie ajustées sur la qualité , Adulte , Asthme/économie , Trouble déficitaire de l'attention avec hyperactivité/économie , Cécité/économie , Paralysie cérébrale/économie , Enfant , Épilepsie/économie , Femelle , Gastroentérite/économie , Perte d'audition/économie , Hospitalisation , Humains , Hypersensibilité/économie , Déficience intellectuelle/économie , Mâle , Otite moyenne/économie , Qualité de vie , Indice de gravité de la maladie
8.
La Paz; 2001. 69 p. tab. (BO).
Thèse de Espagnol | LIBOCS, LIBOSP | ID: biblio-1309376

RÉSUMÉ

Contenido: 2. Fundamentos teoricos, 2. 1 Retraso mental, 2. 2 Lesiones cerebrales, 2. 3 Parálisis cerebral infantil (P. C. I), 2. 4 La terapia ocupacional, 2. 5 Estimulación adecuada, 2. 6 Desarrollo del niño y sus caracteristicas, 3. 1 Adecuación del proyecto a las necesidades de la población objetivo, 3. 2 Evaluación diagnostica y estudio de necesidades, 3. 3 Propuesta, 3. 4 Organización del proyecto, 3. 5 Fundaciones del terapeuta ocupacional, 3. 6 Conclusiones y recomendaciones


Sujet(s)
Communauté thérapeutique , Déficience intellectuelle/classification , Déficience intellectuelle/économie , Ergothérapie/classification , Stimulation physique/méthodes
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE